BSE filing, BSE: 544312. Summary written from the filing by ALFA Finder's alert engine.
Hamps Bio Ltd: key numbers
- Share price
- ₹25.50
- Market cap
- ₹22.22 Cr
- Revenue (annual)
- ₹8.47 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -30.1×Sector 26.8×
- Promoter holding
- 71.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hamps Bio Ltd
All →Hamps Bio Board Meeting Outcome
Hamps Bio Ltd announced the board meeting outcome, approving revised remuneration for its Chairman & Managing Director, Whole Time Director, CFO, and a Director.
Hamps Bio Annual General Meeting
Hamps Bio Ltd held its 19th Annual General Meeting on September 09, 2026, where shareholders transacted the businesses mentioned in the AGM notice.
Hamps Bio Annual Report
Hamps Bio Ltd has submitted its Annual Report for the financial year 2025-26. The report includes the notice of the 19th Annual General Meeting.
Hamps Bio Annual General Meeting
Hamps Bio Ltd has issued a notice for its 19th Annual General Meeting to be held on September 09, 2026.
Hamps Bio Board Meeting Outcome
Hamps Bio Ltd approved its Board Report, the notice for its 19th AGM scheduled for September 9, 2026, and a proposal to shift its registered office.
Hamps Bio Other Announcement
Hamps Bio Ltd updated stock exchange contact details for its Key Managerial Personnel. This is a routine compliance filing under SEBI LODR Regulation 30(5).
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.